Delivery Order SPE2DB22D3010-SPE2DB25FP2GP
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,808.10 to AmerisourceBergen Drug Corp for GVOKE HypoPen 2-Pack (1 mg/0.2 ml) auto-injectors. This firm fixed-price, competitively awarded contract was issued on September 19, 2025, with an ultimate completion date of September 22, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,066.98 to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Gvoke Hypoepen 2-packs (0.5mg/0.1mL auto-injectors). The award was made on a firm fixed-price basis with no set-aside designation, indicating competitive procurement. The contract is scheduled for completion by December 4, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $1,734.47 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Gvoke HypoPen auto-injectors (1 mg/0.2 ml, 2-pack). The contract, which represents a non-competitive delivery order under an existing indefinite delivery vehicle, will be fulfilled from the vendor's Conshohocken, Pennsylvania location with a completion date of September 10, 2025. This award is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,519.71 to AmerisourceBergen Drug Corp for Gvoke HypoPen 2-Pack 1 mg/0.2 ml auto-injectors. This firm fixed-price, competitively awarded contract was executed on August 25, 2025, with an ultimate completion date of August 26, 2025. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order operates as a child contract under AmerisourceBergen's existing indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,639.17 for GVOKE HypoOpen 2-pack auto-injectors (1 mg/0.2 mL) on October 30, 2025, with completion scheduled for October 31, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside provisions and will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $7,308.72 to AmerisourceBergen Drug Corp for the supply of GVOKE HypoPen 2-Pack 1 MG/0.2 ML auto-injectors. This non-competitive delivery order was issued on December 10, 2025, with an ultimate completion date of December 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a firm fixed-price transaction for critical pharmaceutical supplies supporting...
- The Defense Logistics Agency awarded a $21,248.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GVOKE HypoGen 2-pack auto-injectors (1 mg/0.2 ml), with an ultimate completion date of September 5, 2025. This non-set-aside competitive award leverages AmerisourceBergen's comprehensive indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product delivery will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,981.46 to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Gvoke HypoPen 2-pack (1 mg/0.2 mL) auto-injectors. The contract, which is not set aside and was competitively awarded, specifies a firm fixed price structure with an ultimate completion date of June 2, 2025. Performance will be executed from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,752.59 to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of GVOKE HypopenTM auto-injector kits (2-pack, 1 mg/0.2 mL). This firm fixed-price delivery order, with an ultimate completion date of June 2, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running through...
- The Defense Logistics Agency awarded a delivery order valued at $4,087.62 to AmerisourceBergen Drug Corp for GVOKE HypoPen 2-Pack 1 mg/0.2 ml auto-injectors. This competitively awarded, firm fixed-price contract was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The contract involves delivery to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. No set-aside provisions were utilized for this award. This...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB25FP2GPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,669.11 to AmerisourceBergen Drug Corp for the supply of Gvoke Hypoepen 2-pack 1 mg/0.2 ml auto-injectors. This competitively awarded, firm fixed-price delivery order was issued on April 24, 2025, with an ultimate completion date of April 25, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal vendor, serves as a prime supplier for military and veteran healthcare systems through the DLA Medical Supply Chain. The company maintains an extensive portfolio of pharmaceutical and medical supply deliveries across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. This specific delivery order for glucagon auto-injector emergency treatment kits supports the Defense Health Agency's medical supply requirements. As a leading pharmaceutical prime vendor, AmerisourceBergen competes in the open market for federal medical procurement and is positioned as one of multiple anticipated awardees under the DLA's Pharmaceutical Prime Vendor Global Program Generation V contracts across designated regions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 4/24/25 |